skip to main content

News Archive

Date: 08/15/2023
Using tissue samples and cell models from patients, Joshi Alumkal, M.D., Wicha Family Professor of Oncology and leader of the genitourinary medical oncology section at Rogel, and his team zeroed in on the lysine specific demethylase 1, a protein involved in turning genes off and on in normal and cancer cells that appears particularly important in certain aggressive forms of prostate cancer.
Date: 08/14/2023
Research from experts at Michigan Medicine, the Children’s Hospital of Philadelphia and Penn Medicine is breaking ground on new ways of treating blood disorders, such as sickle cell anemia, through gene therapy.
Date: 08/14/2023
The findings show that the patients who had renal tumors with TFEB amplification were significantly older than patients with renal tumors housing TFE3 or TFEB translocation. Further, renal tumors with TFEB amplification, known to be associated with poor prognosis, were seen to be at least three times as common as those with TFEB translocation.
Date: 08/01/2023
The University of Michigan Health Rogel Cancer Center has been recognized as the top cancer program in Michigan, according to U.S. News and World Report’s Best Hospitals Rankings for 2023-2024. U-M has the only ranked cancer program in the state.
Date: 07/21/2023
Bhramar Mukherjee, John D. Kalbfleisch Collegiate Professor and chair of Biostatistics at the University of Michigan School of Public Health, has been awarded the university’s highest professorship of Distinguished University Professor. Established in 1947, the Distinguished University Professorship recognizes exceptional senior faculty and their contributions to academic excellence.
Date: 07/12/2023
An analysis finds that up to millions of dollars could be saved annually on cancer immunotherapy treatments across the Veterans Health Administration by reconsidering how those drugs are delivered.
Date: 06/30/2023
Cancerous brain tumor cells may be at ‘critical point’ between order and disorder. Large-scale coordination of brain tumor behavior may allow tumor cells to resist better against therapies such as chemotherapy and radiation, researchers say.
Date: 06/27/2023
The National Cancer Institute has awarded the University of Michigan Rogel Cancer Center a grant worth $37 million over five years. At the same time, the center’s designation as a “comprehensive cancer center” was renewed. The grant is a renewal of the Rogel Cancer Center’s support grant, provided as part of the NCI’s cancer centers program. Rogel first received NCI designation in 1988 and was designated comprehensive just three years later. The new grant provides funding through 2028, extending Rogel to 40 consecutive years of funding. The $36.7 million represents a 10% increase over the previous support grant.
Date: 06/26/2023
The University of Michigan is developing two academic and scientific partnerships in Singapore that are expected to create opportunities for joint research, trainee and student exchange, and more. One of the partnerships is with the National University of Singapore’s Cancer Science Institute and the National University Cancer Institute, Singapore. The other partnership is between the U-M Rogel Cancer Center and the National Cancer Centre Singapore.
Date: 06/12/2023
Germline genetic testing, in which inherited DNA is sequenced, is recommended for patients diagnosed with cancer to enable genetically targeted treatment and identify additional relatives who can benefit from personalized cancer screening and prevention. Not enough people are getting genetic testing for cancer, according to recent research.